A critique of ethics discussions on access to aging treatments, emphasizing information and literacy barriers over financial ones.
Key Takeaways
- Or will only be available to the wealthy
- Well-studied initial approaches to treat aging are also readily available at generic drug prices
- Or they are free if we're also counting exercise and calorie restriction